RhumbLine Advisers’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.8M | Buy |
484,909
+19,588
| +4% | +$1.8M | 0.04% | 395 |
|
|
2025
Q4 | $41.8M | Buy |
465,321
+7,057
| +2% | +$669K | 0.03% | 423 |
|
|
2025
Q3 | $45.1M | Buy |
458,264
+2,059
| +0.5% | +$204K | 0.04% | 402 |
|
|
2025
Q2 | $41.6M | Buy |
456,205
+29,678
| +7% | +$2.87M | 0.04% | 420 |
|
|
2025
Q1 | $48.3M | Buy |
426,527
+22,889
| +6% | +$2.45M | 0.05% | 351 |
|
|
2024
Q4 | $42.6M | Sell |
403,638
-8,413
| -2% | -$903K | 0.04% | 386 |
|
|
2024
Q3 | $44.5M | Sell |
412,051
-3,728
| -0.9% | -$407K | 0.04% | 374 |
|
|
2024
Q2 | $45.1M | Sell |
415,779
-15,363
| -4% | -$1.81M | 0.04% | 358 |
|
|
2024
Q1 | $56.9M | Buy |
431,142
+8,355
| +2% | +$1.04M | 0.05% | 297 |
|
|
2023
Q4 | $51.5M | Sell |
422,787
-3,194
| -0.7% | -$356K | 0.05% | 301 |
|
|
2023
Q3 | $47.8M | Sell |
425,981
-8,871
| -2% | -$1.13M | 0.06% | 296 |
|
|
2023
Q2 | $63.3M | Sell |
434,852
-1,270
| -0.3% | -$173K | 0.07% | 247 |
|
|
2023
Q1 | $56.3M | Buy |
436,122
+10,707
| +3% | +$1.34M | 0.07% | 259 |
|
|
2022
Q4 | $54.2M | Buy |
425,415
+14,642
| +4% | +$1.7M | 0.07% | 254 |
|
|
2022
Q3 | $42.9M | Buy |
410,773
+16,358
| +4% | +$1.8M | 0.06% | 277 |
|
|
2022
Q2 | $41.4M | Buy |
394,415
+19,413
| +5% | +$2.3M | 0.06% | 284 |
|
|
2022
Q1 | $48M | Sell |
375,002
-65
| -0% | -$7.83K | 0.06% | 276 |
|
|
2021
Q4 | $46.3M | Buy |
375,067
+7,446
| +2% | +$975K | 0.06% | 297 |
|
|
2021
Q3 | $52.2M | Sell |
367,621
-2,803
| -0.8% | -$412K | 0.07% | 237 |
|
|
2021
Q2 | $57.8M | Sell |
370,424
-3,884
| -1% | -$629K | 0.08% | 230 |
|
|
2021
Q1 | $58.2M | Sell |
374,308
-22,132
| -6% | -$3.43M | 0.08% | 221 |
|
|
2020
Q4 | $59.3M | Buy |
396,440
+6,971
| +2% | +$985K | 0.08% | 214 |
|
|
2020
Q3 | $51.5M | Sell |
389,469
-1,814
| -0.5% | -$237K | 0.08% | 221 |
|
|
2020
Q2 | $45.3M | Sell |
391,283
-7,887
| -2% | -$909K | 0.08% | 224 |
|
|
2020
Q1 | $39.2M | Buy |
399,170
+29,125
| +8% | +$3.82M | 0.08% | 219 |
|
|
2019
Q4 | $53.8M | Buy |
370,045
+11,813
| +3% | +$1.63M | 0.09% | 209 |
|
|
2019
Q3 | $47.7M | Buy |
358,232
+6,948
| +2% | +$898K | 0.09% | 214 |
|
|
2019
Q2 | $40.2M | Buy |
351,284
+2,322
| +0.7% | +$272K | 0.08% | 234 |
|
|
2019
Q1 | $43.3M | Sell |
348,962
-32,136
| -8% | -$3.65M | 0.08% | 211 |
|
|
2018
Q4 | $38.4M | Buy |
381,098
+1,134
| +0.3% | +$128K | 0.08% | 221 |
|
|
2018
Q3 | $48.5M | Sell |
379,964
-9,282
| -2% | -$1.1M | 0.09% | 204 |
|
|
2018
Q2 | $42.1M | Sell |
389,246
-5,083
| -1% | -$553K | 0.08% | 229 |
|
|
2018
Q1 | $41.7M | Sell |
394,329
-1,655
| -0.4% | -$192K | 0.09% | 232 |
|
|
2017
Q4 | $46.4M | Buy |
395,984
+8,669
| +2% | +$980K | 0.09% | 216 |
|
|
2017
Q3 | $44M | Buy |
387,315
+10,517
| +3% | +$1.21M | 0.1% | 219 |
|
|
2017
Q2 | $47M | Buy |
376,798
+1,637
| +0.4% | +$194K | 0.11% | 201 |
|
|
2017
Q1 | $44.5M | Buy |
375,161
+8,978
| +2% | +$1.02M | 0.1% | 208 |
|
|
2016
Q4 | $36.7M | Buy |
366,183
+22,266
| +6% | +$2.39M | 0.09% | 227 |
|
|
2016
Q3 | $43.4M | Buy |
343,917
+26,999
| +9% | +$3.34M | 0.12% | 179 |
|
|
2016
Q2 | $37M | Buy |
316,918
+52,803
| +20% | +$5.98M | 0.11% | 192 |
|
|
2016
Q1 | $27.3M | Buy |
264,115
+17,899
| +7% | +$1.73M | 0.08% | 242 |
|
|
2015
Q4 | $24.5M | Sell |
246,216
-63
| -0% | -$6.16K | 0.08% | 251 |
|
|
2015
Q3 | $22.5M | Buy |
246,279
+6,535
| +3% | +$655K | 0.08% | 262 |
|
|
2015
Q2 | $25.4M | Buy |
239,744
+10,889
| +5% | +$1.2M | 0.08% | 247 |
|
|
2015
Q1 | $26.1M | Sell |
228,855
-14,187
| -6% | -$1.62M | 0.08% | 241 |
|
|
2014
Q4 | $26.8M | Buy |
243,042
+9,503
| +4% | +$1M | 0.08% | 239 |
|
|
2014
Q3 | $22.8M | Sell |
233,539
-6,524
| -3% | -$642K | 0.07% | 255 |
|
|
2014
Q2 | $24.2M | Sell |
240,063
-5,792
| -2% | -$565K | 0.07% | 254 |
|
|
2014
Q1 | $22.6M | Buy |
245,855
+1,792
| +0.7% | +$165K | 0.07% | 272 |
|
|
2013
Q4 | $22.1M | Sell |
244,063
-13,939
| -5% | -$1.21M | 0.07% | 278 |
|
|
2013
Q3 | $20.6M | Buy |
258,002
+719
| +0.3% | +$56.6K | 0.06% | 297 |
|
|
2013
Q2 | $18.7M | Buy |
+257,283
| New | +$19.2M | 0.06% | 302 |
|
Other funds holding ZBH
VCM
VPM
RhumbLine Advisers's ZBH Position: Q1 2026 in Review
RhumbLine Advisers increased its Zimmer Biomet (ZBH) stake by 4.2% in Q1 2026, buying an estimated $1.8M and bringing the position to 484,909 shares worth $43.8M. The position accounts for 0.04% of the portfolio, ranked #395.
RhumbLine Advisers first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $63.3M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- RhumbLine Advisers held 484,909 shares of Zimmer Biomet worth $43.8M as of Q1 2026.
- RhumbLine Advisers bought 19,588 Zimmer Biomet shares in Q1 2026, an estimated $1.8M.
- Zimmer Biomet made up 0.04% of RhumbLine Advisers's portfolio in Q1 2026, its #395 holding.
- RhumbLine Advisers first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's Zimmer Biomet position peaked at $63.3M in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.